Placement of Aortic Transcatheter Valves (Cohort B): Transfemoral TAVR vs. Medical Management | Clinical Trial - PARTNER Cohort B: Transfemoral TAVR vs. Medical Management

Description:

As many as one-third of patients with severe aortic stenosis (AS) are high-risk surgical candidates and are conservatively managed. However, nonsurgical management of symptomatic AS is associated with a median survival of about 2 years. The PARTNER trial sought to compare outcomes between standard therapy and transcatheter aortic valve replacement (TAVR) in patients with inoperable AS. TAVR is a new procedure in which a bioprosthetic aortic valve is inserted through a catheter and implanted w...